Data / Form D filings / Paratus Diagnostics, LLC
Paratus Diagnostics, LLC: Form D filings
Paratus Diagnostics, LLC, a biotechnology company in San Marcos, TX, filed 3 Form D notices with the SEC between 2015 and 2018. The latest, on November 29, 2018, reports $5.2 million sold of a $8.2 million offering to 43 investors.
Find out what Paratus Diagnostics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3055 Hunter Road, San Marcos, TX, 78666
- Phone
- (512) 245-1050
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661922
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | New notice | $8,205,000 | $5,205,000 | $3,000,000 | 43 | Nov 16, 2018 | sec.gov |
| Jul 21, 2016 | New notice | $3,100,000 | $2,800,000 | $300,000 | 43 | Jul 11, 2016 | sec.gov |
| Dec 28, 2015 | New notice | $1,006,000 | $100,000 | $906,000 | 1 | Dec 22, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael C. Matula | Director | |
| Robert C. Donnelly | Director | |
| Roland Q Schneider | Director | |
| John C. Carrano | Executive Officer, Director | |
| Gene C. Betts | Director | |
| Phil C. Jones | Director | |
| Wayne Q Radwanski | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 26, 2018 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Paratus Diagnostics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.